Pharmaceutical Contract Manufacturing Market Report 2020-2030

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry.

SKU: PHA0519 Category: Contract Services Tags: PHA0406, PHA0519, PHA0783, PHA0810, PHA0973, PHA1137, PHA1141, PHA1149 Code: PHA0519Pages: 543

Download Sample Form

"*" indicates required fields

Name*

Company*

Designation*

Job Title

Industry

Email*

Phone*

Address*

This field is hidden when viewing the form

Report Title

This field is hidden when viewing the form

Sample url

← Back to category Contract Services

Description

Pharmaceutical Contract Manufacturing,our new study reveals trends, R&D progress, and predicted revenues
Where is the Pharmaceutical Contract Manufacturing market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 543 page report provides 700+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Pharmaceutical Contract Manufacturing Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email contactus@visiongain.com

Discover sales predictions for the world market and submarkets

Product Category
• Pharmaceutical Product Manufacturing
• Biological Product Manufacturing

Drug Type
• API Manufacturing
• FDF Manufacturing

API
• Small Molecule
• Large Molecule
• High Potency API (HPAPI)

FDF
• Solid Dose Formulation
• Liquid Dose Formulation
• Injectable Dose Formulation
• Other FDFs

By End-User
• Big Pharma
• Small & Mid-size Pharma
• Generic Pharmaceutical Companies
• Other End-Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

• North America
– U.S.
– Canada

• Europe
– Germany
– France
– United Kingdom
– Italy
– Spain
– Rest of Europe

• Asia Pacific
– China
– Japan
– India
– Australia
– South Korea
– Rest of Asia Pacific

• Latin America
– Brazil
– Mexico
– Argentina
– Rest of Latin America

• Middle East and Africa
– Turkey
– Saudi Arabia
– South Africa
– UAE
– Egypt
– Rest of Middle East and Africa

The report also includes profiles and for some of the leading companies in the Pharmaceutical Contract Manufacturing Market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall world revenue for Pharmaceutical Contract Manufacturing Market will surpass million in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Pharmaceutical Contract Manufacturing Market report helps you
In summary, our 543 page report provides you with the following knowledge:

• Revenue forecasts to 2030 for Pharmaceutical Contract Manufacturing Market, with forecasts for Product Category, Drug Type, API, FDF, and End User, each forecasted at a global and regional level, discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2030 for 5 regional and 16 key national markets , See forecasts for the Pharmaceutical Contract Manufacturing market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market, including company profiles for 13 of the major companies involved in the Pharmaceutical Contract Manufacturing Market. Some of the company’s profiled in this report include Catalent Inc., Lonza Group AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Mylan NV, AbbVie Inc., Piramal Enterprises Ltd, Consort Medical plc, Baxter International Inc, Alkermes Plc, Bayer AG, GlaxoSmithKline plc, and NIPRO CORPORATION.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Pharmaceutical Contract Manufacturing Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Pharmaceutical Contract Manufacturing Market Report 2020-2030: Forecasts by Product Category (Pharmaceutical Product Manufacturing, Biological Product Manufacturing), by Drug Type (API Manufacturing, FDF Manufacturing), by API (Small Molecule, Large Molecule, High Potency API (HPAPI)), by FDF (Solid Dose Formulation, Liquid Dose Formulation, Injectable Dose Formulation, Other FDFs), by End-user (Big Pharma, Small & Mid-size Pharma, Generic Pharmaceutical Companies, Other End-users). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed , order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1 Report Overview 1.1 Scope of Report 1.2 Why You Should Buy This Report 1.3 How This Report Delivers 1.4 Key Questions Answered by This Analytical Report Include: 1.5 Who is This Report For? 1.6 Methodology 1.6.1 Primary Research 1.6.2 Secondary Research 1.7 Market Evaluation & Forecasting Methodology 1.8 COIVD-19 Impact Recovery Pattern Analysis 1.8.1 V-Shaped Recovery 1.8.2 U-Shaped Recovery 1.8.3 W-Shaped Recovery 1.8.4 L-Shaped Recovery 1.9 Frequently Asked Questions (FAQ) 1.10 Associated Visiongain Reports 1.11 About Visiongain 2 Executive Summary 2.1 Pharmaceutical Product Manufacturing Segment is Expected to Maintain its Dominance in the Global Market 2.2 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market 3 Market Dynamics 3.1 Factors Affecting Growth 3.1.1 Product and Process Innovation 3.1.2 Continuing Focus on Productivity 3.1.3 Cost Savings 3.1.4 Risk Management 3.1.5 Stringent Regulations 3.1.6 Patent Expirations 3.1.7 Decreasing Research and Development Success Rates 3.2 Market Drivers 3.2.1 Increasing Demand of Biosimilars 3.2.2 Increased Focus on Orphan and Specialty Drugs 3.2.3 Generics: A Driver or Restraint? 3.2.4 Increasing Demand for Formulation Development Services 3.2.5 Bio/Pharmaceutical Manufacturers' Move Toward Strategic Collaboration With Drug Delivery Technology Companies 3.3 Opportunities in the Global Market 3.3.1 Lack of Manufacturing and Packaging Capabilities 3.3.2 Pharma Companies Will Continue To Look For Ways To Cut Drug Costs 3.3.3 Need for New Drug Delivery Technologies 3.3.4 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs 3.4 Growth Restrain 3.4.1 Backwards Integration for Generics Manufacturers 3.4.2 The US Generic Drug User Fee Act and API Manufacturing 3.5 Challenges in Contract Manufacturing 3.5.1 Challenges in Assessing the Market: Supply versus Demand 3.6 SWOT Analysis 3.7 Porter's Five Forces Analysis 3.7.1 What are Porter Five (5) Forces 3.7.2 Threat of New Entrants (Low to Moderate) 3.7.3 Rivalry Among the Existing Players (High) 3.7.4 Bargaining Power of Suppliers (Low) 3.7.5 Threats from Substitute Products (Low to Moderate) 3.7.6 Bargaining Power of Buyers (High) 4 Global Pharmaceutical Contract Manufacturing Market 4.1 Industry Structure Overview 4.1.1 Pharmaceutical Landscape 4.1.2 Objectives of Outsourcing 4.1.3 Contract Manufacturing Types 4.1.4 Suitable Services Provider 4.1.5 Benefits of Outsourcing 4.1.6 Drawbacks of Outsourcing 4.1.7 Outsourcing 4.1.8 Core Capabilities of Contract Manufacturing Organization 4.1.9 Services Offered by Contract Manufacturing Organizations 5 Global Pharmaceutical Contract Manufacturing Market 5.1 Overview 5.1.1 Analysis of Market Status Before COVID-19 5.1.2 Analysis of Market V-Shaped Recovery Pattern 5.1.3 Analysis of Market W-Shaped Recovery Pattern 5.1.4 Analysis of Market U-Shaped Recovery Pattern 5.1.5 Analysis of Market L-Shaped Recovery Pattern 5.2 Regional Market Overview 5.2.1 Analysis of Market Status Before COVID-19 5.2.2 Analysis of Market V-Shaped Recovery Pattern 5.2.3 Analysis of Market W-Shaped Recovery Pattern 5.2.4 Analysis of Market U-Shaped Recovery Pattern 5.2.5 Analysis of Market L-Shaped Recovery Pattern 5.3 Product Category Market Overview 5.3.1 Analysis of Market Status Before COVID-19 5.3.2 Analysis of Market V-Shaped Recovery Pattern 5.3.3 Analysis of Market W-Shaped Recovery Pattern 5.3.4 Analysis of Market U-Shaped Recovery Pattern 5.3.5 Analysis of Market L-Shaped Recovery Pattern 5.4 Drug Type Market Overview 5.4.1 Analysis of Market Status Before COVID-19 5.4.2 Analysis of Market V-Shaped Recovery Pattern 5.4.3 Analysis of Market W-Shaped Recovery Pattern 5.4.4 Analysis of Market U-Shaped Recovery Pattern 5.4.5 Analysis of Market L-Shaped Recovery Pattern 5.5 API Contract Manufacturing Market Overview 5.5.1 Analysis of Market Status Before COVID-19 5.5.2 Analysis of Market V-Shaped Recovery Pattern 5.5.3 Analysis of Market W-Shaped Recovery Pattern 5.5.4 Analysis of Market U-Shaped Recovery Pattern 5.5.5 Analysis of Market L-Shaped Recovery Pattern 5.6 FDF Contract Manufacturing Market Overview 5.6.1 Analysis of Market Status Before COVID-19 5.6.2 Analysis of Market V-Shaped Recovery Pattern 5.6.3 Analysis of Market W-Shaped Recovery Pattern 5.6.4 Analysis of Market U-Shaped Recovery Pattern 5.6.5 Analysis of Market L-Shaped Recovery Pattern 5.7 End-User Market Overview 5.7.1 Analysis of Market Status Before COVID-19 5.7.2 Analysis of Market V-Shaped Recovery Pattern 5.7.3 Analysis of Market W-Shaped Recovery Pattern 5.7.4 Analysis of Market U-Shaped Recovery Pattern 5.7.5 Analysis of Market L-Shaped Recovery Pattern 6 Global Market Analysis by Product Category 6.1 Pharmaceutical Product Manufacturing Market Analysis by Region 6.1.1 Market Overview 6.1.2 Analysis of Market Status Before COVID-19 6.1.3 Analysis of Market V-Shaped Recovery Pattern 6.1.4 Analysis of Market W-Shaped Recovery Pattern 6.1.5 Analysis of Market U-Shaped Recovery Pattern 6.1.6 Analysis of Market L-Shaped Recovery Pattern 6.2 Biological Product Manufacturing Market Analysis by Region 6.2.1 Market Overview 6.2.2 Analysis of Market Status Before COVID-19 6.2.3 Analysis of Market V-Shaped Recovery Pattern 6.2.4 Analysis of Market W-Shaped Recovery Pattern 6.2.5 Analysis of Market U-Shaped Recovery Pattern 6.2.6 Analysis of Market L-Shaped Recovery Pattern 7 Global Market Analysis by Drug Type 7.1 Active Pharmaceutical Ingredient Manufacturing Market Analysis by Region 7.1.1 Market Overview 7.1.2 Analysis of Market Status Before COVID-19 7.1.3 Analysis of Market V-Shaped Recovery Pattern 7.1.4 Analysis of Market W-Shaped Recovery Pattern 7.1.5 Analysis of Market U-Shaped Recovery Pattern 7.1.6 Analysis of Market L-Shaped Recovery Pattern 7.2 Finished Dosage Form Products Manufacturing Market Analysis by Region 7.2.1 Analysis of Market Status Before COVID-19 7.2.2 Analysis of Market V-Shaped Recovery Pattern 7.2.3 Analysis of Market W-Shaped Recovery Pattern 7.2.4 Analysis of Market U-Shaped Recovery Pattern 7.2.5 Analysis of Market L-Shaped Recovery Pattern 8 Global Market Analysis by Active Pharmaceutical Ingredients Contract Manufacturing 8.1 API Small Molecule Manufacturing Market Analysis by Region 8.1.1 Analysis of Market Status Before COVID-19 8.1.2 Analysis of Market V-Shaped Recovery Pattern 8.1.3 Analysis of Market W-Shaped Recovery Pattern 8.1.4 Analysis of Market U-Shaped Recovery Pattern 8.1.5 Analysis of Market L-Shaped Recovery Pattern 8.2 API Large Molecule Manufacturing Market Analysis by Region 8.2.1 Analysis of Market Status Before COVID-19 8.2.2 Analysis of Market V-Shaped Recovery Pattern 8.2.3 Analysis of Market W-Shaped Recovery Pattern 8.2.4 Analysis of Market U-Shaped Recovery Pattern 8.2.5 Analysis of Market L-Shaped Recovery Pattern 8.3 High Potency API (HPAPI) Manufacturing Market Analysis by Region 8.3.1 Challenges and Opportunities in High Containment Manufacturing 8.3.2 Analysis of Market Status Before COVID-19 8.3.3 Analysis of Market V-Shaped Recovery Pattern 8.3.4 Analysis of Market W-Shaped Recovery Pattern 8.3.5 Analysis of Market U-Shaped Recovery Pattern 8.3.6 Analysis of Market L-Shaped Recovery Pattern 9 Global Market Analysis by Finished Dosage Form Contract Manufacturing 9.1 Solid Dose Formulation Manufacturing Market Analysis by Region 9.1.1 Market Overview 9.1.2 Analysis of Market Status Before COVID-19 9.1.3 Analysis of Market V-Shaped Recovery Pattern 9.1.4 Analysis of Market W-Shaped Recovery Pattern 9.1.5 Analysis of Market U-Shaped Recovery Pattern 9.1.6 Analysis of Market L-Shaped Recovery Pattern 9.2 Liquid Dose Formulation Manufacturing Market Analysis by Region 9.2.1 Market Overview 9.2.2 Nonsterile Formulations 9.2.3 Analysis of Market Status Before COVID-19 9.2.4 Analysis of Market V-Shaped Recovery Pattern 9.2.5 Analysis of Market W-Shaped Recovery Pattern 9.2.6 Analysis of Market U-Shaped Recovery Pattern 9.2.7 Analysis of Market L-Shaped Recovery Pattern 9.3 Injectable Dose Formulation Manufacturing Market Analysis by Region 9.3.1 Sterile Formulations 9.3.2 Analysis of Market Status Before COVID-19 9.3.3 Analysis of Market V-Shaped Recovery Pattern 9.3.4 Analysis of Market W-Shaped Recovery Pattern 9.3.5 Analysis of Market U-Shaped Recovery Pattern 9.3.6 Analysis of Market L-Shaped Recovery Pattern 9.4 Other FDF Dose Formulation Manufacturing Market Analysis by Region 9.4.1 Semi-Solid Dosage Forms 9.4.2 Advanced Drug Delivery Products 9.4.3 Market Overview 9.4.4 Analysis of Market Status Before COVID-19 9.4.5 Analysis of Market V-Shaped Recovery Pattern 9.4.6 Analysis of Market W-Shaped Recovery Pattern 9.4.7 Analysis of Market U-Shaped Recovery Pattern 9.4.8 Analysis of Market L-Shaped Recovery Pattern 10 Global Market Analysis by End-User 10.1 Big Pharmaceutical Contract Manufacturing Market Analysis by Region 10.1.1 Analysis of Market Status Before COVID-19 10.1.2 Analysis of Market V-Shaped Recovery Pattern 10.1.3 Analysis of Market W-Shaped Recovery Pattern 10.1.4 Analysis of Market U-Shaped Recovery Pattern 10.1.5 Analysis of Market L-Shaped Recovery Pattern 10.2 Small & Mid-size Pharmaceutical Contract Manufacturing Market Analysis by Region 10.2.1 Analysis of Market Status Before COVID-19 10.2.2 Analysis of Market V-Shaped Recovery Pattern 10.2.3 Analysis of Market W-Shaped Recovery Pattern 10.2.4 Analysis of Market U-Shaped Recovery Pattern 10.2.5 Analysis of Market L-Shaped Recovery Pattern 10.3 Generic Pharmaceutical Companies Contract Manufacturing Market Analysis by Region 10.3.1 Analysis of Market Status Before COVID-19 10.3.2 Analysis of Market V-Shaped Recovery Pattern 10.3.3 Analysis of Market W-Shaped Recovery Pattern 10.3.4 Analysis of Market U-Shaped Recovery Pattern 10.3.5 Analysis of Market L-Shaped Recovery Pattern 10.4 Other End-User Contract Manufacturing Market Analysis by Region 10.4.1 Analysis of Market Status Before COVID-19 10.4.2 Analysis of Market V-Shaped Recovery Pattern 10.4.3 Analysis of Market W-Shaped Recovery Pattern 10.4.4 Analysis of Market U-Shaped Recovery Pattern 10.4.5 Analysis of Market L-Shaped Recovery Pattern 11 North America Pharmaceutical Contract Manufacturing Market Analysis 11.1 North America Market in Terms of Value 11.1.1 Analysis of Market Status Before COVID-19 11.1.2 Analysis of Market V-Shaped Recovery Pattern 11.1.3 Analysis of Market W-Shaped Recovery Pattern 11.1.4 Analysis of Market U-Shaped Recovery Pattern 11.1.5 Analysis of Market L-Shaped Recovery Pattern 11.2 US Pharmaceutical Contract Manufacturing Market Analysis 11.2.1 Pharmaceutical Manufacturing in the US: Regulatory Oversight, 2019 11.2.2 Controlling Foreign Manufacturing Sites 11.2.3 Outsourcing and US Manufacturing Regulations 11.2.4 Increased Demand for Domestic API Manufacturing? 11.2.5 Analysis of Market Status Before COVID-19 11.2.6 Analysis of Market V-Shaped Recovery Pattern 11.2.7 Analysis of Market W-Shaped Recovery Pattern 11.2.8 Analysis of Market U-Shaped Recovery Pattern 11.2.9 Analysis of Market L-Shaped Recovery Pattern 11.3 Canada Pharmaceutical Contract Manufacturing Market Analysis 11.3.1 Analysis of Market Status Before COVID-19 11.3.2 Analysis of Market V-Shaped Recovery Pattern 11.3.3 Analysis of Market W-Shaped Recovery Pattern 11.3.4 Analysis of Market U-Shaped Recovery Pattern 11.3.5 Analysis of Market L-Shaped Recovery Pattern 11.4 North America Market Analysis by Product Category 11.4.1 Analysis of Market Status Before COVID-19 11.4.2 Analysis of Market V-Shaped Recovery Pattern 11.4.3 Analysis of Market W-Shaped Recovery Pattern 11.4.4 Analysis of Market U-Shaped Recovery Pattern 11.4.5 Analysis of Market L-Shaped Recovery Pattern 11.5 North America Market Analysis by Drug Type 11.5.1 Analysis of Market Status Before COVID-19 11.5.2 Analysis of Market V-Shaped Recovery Pattern 11.5.3 Analysis of Market W-Shaped Recovery Pattern 11.5.4 Analysis of Market U-Shaped Recovery Pattern 11.5.5 Analysis of Market L-Shaped Recovery Pattern 11.6 North America Market Analysis by API Contract Manufacturing 11.6.1 Analysis of Market Status Before COVID-19 11.6.2 Analysis of Market V-Shaped Recovery Pattern 11.6.3 Analysis of Market W-Shaped Recovery Pattern 11.6.4 Analysis of Market U-Shaped Recovery Pattern 11.6.5 Analysis of Market L-Shaped Recovery Pattern 11.7 North America Market Analysis by FDF Contract Manufacturing 11.7.1 Analysis of Market Status Before COVID-19 11.7.2 Analysis of Market V-Shaped Recovery Pattern 11.7.3 Analysis of Market W-Shaped Recovery Pattern 11.7.4 Analysis of Market U-Shaped Recovery Pattern 11.7.5 Analysis of Market L-Shaped Recovery Pattern 11.8 North America Market Analysis by End-User 11.8.1 Analysis of Market Status Before COVID-19 11.8.2 Analysis of Market V-Shaped Recovery Pattern 11.8.3 Analysis of Market W-Shaped Recovery Pattern 11.8.4 Analysis of Market U-Shaped Recovery Pattern 11.8.5 Analysis of Market L-Shaped Recovery Pattern 12 Europe Pharmaceutical Contract Manufacturing Market Analysis 12.1.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing 12.1.2 Regulatory Aspects of Pharma Manufacturing in the EU 12.1.3 The European Commission Amends Annex 16 12.1.4 The Falsified Medicine Directive: Controlling API Imports 12.1.5 Biopharma Manufacturing Demand Will Rise 12.1.6 The EU Contract Manufacturing Market Forecast 2020-2030 12.2 Europe Market in Terms of Value 12.2.1 Analysis of Market Status Before COVID-19 12.2.2 Analysis of Market V-Shaped Recovery Pattern 12.2.3 Analysis of Market W-Shaped Recovery Pattern 12.2.4 Analysis of Market U-Shaped Recovery Pattern 12.2.5 Analysis of Market L-Shaped Recovery Pattern 12.3 Germany Pharmaceutical Contract Manufacturing Market Analysis 12.3.1 Germany: The Leading EU Destination for API and FDF Manufacturing 12.3.2 Demand for Contract Manufacturing in Germany 12.3.3 Analysis of Market Status Before COVID-19 12.3.4 Analysis of Market V-Shaped Recovery Pattern 12.3.5 Analysis of Market W-Shaped Recovery Pattern 12.3.6 Analysis of Market U-Shaped Recovery Pattern 12.3.7 Analysis of Market L-Shaped Recovery Pattern 12.4 France Pharmaceutical Contract Manufacturing Market Analysis 12.4.1 Analysis of Market Status Before COVID-19 12.4.2 Analysis of Market V-Shaped Recovery Pattern 12.4.3 Analysis of Market W-Shaped Recovery Pattern 12.4.4 Analysis of Market U-Shaped Recovery Pattern 12.4.5 Analysis of Market L-Shaped Recovery Pattern 12.5 UK Pharmaceutical Contract Manufacturing Market Analysis 12.5.1 Analysis of Market Status Before COVID-19 12.5.2 Analysis of Market V-Shaped Recovery Pattern 12.5.3 Analysis of Market W-Shaped Recovery Pattern 12.5.4 Analysis of Market U-Shaped Recovery Pattern 12.5.5 Analysis of Market L-Shaped Recovery Pattern 12.6 Italy Pharmaceutical Contract Manufacturing Market Analysis 12.6.1 Italy: Strong API Manufacturing Traditions 12.6.2 Revenue Forecast for the Italian Pharma Contract Manufacturing 12.6.3 Analysis of Market Status Before COVID-19 12.6.4 Analysis of Market V-Shaped Recovery Pattern 12.6.5 Analysis of Market W-Shaped Recovery Pattern 12.6.6 Analysis of Market U-Shaped Recovery Pattern 12.6.7 Analysis of Market L-Shaped Recovery Pattern 12.7 Spain Pharmaceutical Contract Manufacturing Market Analysis 12.7.1 Spain: How Will Demand for Manufacturing Services Grow? 12.7.2 Analysis of Market Status Before COVID-19 12.7.3 Analysis of Market V-Shaped Recovery Pattern 12.7.4 Analysis of Market W-Shaped Recovery Pattern 12.7.5 Analysis of Market U-Shaped Recovery Pattern 12.7.6 Analysis of Market L-Shaped Recovery Pattern 12.8 Rest of Europe Pharmaceutical Contract Manufacturing Market Analysis 12.8.1 Compliance with GMP in Russia 12.8.2 How Will Demand for Contract Manufacturing Grow in Russia to 2030? 12.8.3 Analysis of Market Status Before COVID-19 12.8.4 Analysis of Market V-Shaped Recovery Pattern 12.8.5 Analysis of Market W-Shaped Recovery Pattern 12.8.6 Analysis of Market U-Shaped Recovery Pattern 12.8.7 Analysis of Market L-Shaped Recovery Pattern 12.9 Europe Market Analysis by Product Category 12.9.1 Analysis of Market Status Before COVID-19 12.9.2 Analysis of Market V-Shaped Recovery Pattern 12.9.3 Analysis of Market W-Shaped Recovery Pattern 12.9.4 Analysis of Market U-Shaped Recovery Pattern 12.9.5 Analysis of Market L-Shaped Recovery Pattern 12.10 Europe Market Analysis by Drug Type 12.10.1 Analysis of Market Status Before COVID-19 12.10.2 Analysis of Market V-Shaped Recovery Pattern 12.10.3 Analysis of Market W-Shaped Recovery Pattern 12.10.4 Analysis of Market U-Shaped Recovery Pattern 12.10.5 Analysis of Market L-Shaped Recovery Pattern 12.11 Europe Market Analysis by API Contract Manufacturing 12.11.1 Analysis of Market Status Before COVID-19 12.11.2 Analysis of Market V-Shaped Recovery Pattern 12.11.3 Analysis of Market W-Shaped Recovery Pattern 12.11.4 Analysis of Market U-Shaped Recovery Pattern 12.11.5 Analysis of Market L-Shaped Recovery Pattern 12.12 Europe Market Analysis by FDF Contract Manufacturing 12.12.1 Analysis of Market Status Before COVID-19 12.12.2 Analysis of Market V-Shaped Recovery Pattern 12.12.3 Analysis of Market W-Shaped Recovery Pattern 12.12.4 Analysis of Market U-Shaped Recovery Pattern 12.12.5 Analysis of Market L-Shaped Recovery Pattern 12.13 Europe Market Analysis by End-User 12.13.1 Analysis of Market Status Before COVID-19 12.13.2 Analysis of Market V-Shaped Recovery Pattern 12.13.3 Analysis of Market W-Shaped Recovery Pattern 12.13.4 Analysis of Market U-Shaped Recovery Pattern 12.13.5 Analysis of Market L-Shaped Recovery Pattern 13 Asia-Pacific Pharmaceutical Contract Manufacturing Market Analysis 13.1.1 Demand Will Increase for Services in India and China 13.2 Asia-Pacific Market in Terms of Value 13.2.1 Analysis of Market Status Before COVID-19 13.2.2 Analysis of Market V-Shaped Recovery Pattern 13.2.3 Analysis of Market W-Shaped Recovery Pattern 13.2.4 Analysis of Market U-Shaped Recovery Pattern 13.2.5 Analysis of Market L-Shaped Recovery Pattern 13.3 Japan Pharmaceutical Contract Manufacturing Market Analysis 13.3.1 Pharmaceutical Manufacturing Regulations in Japan 13.3.2 The Pharmaceutical Affairs Law 13.3.3 Analysis of Market Status Before COVID-19 13.3.4 Analysis of Market V-Shaped Recovery Pattern 13.3.5 Analysis of Market W-Shaped Recovery Pattern 13.3.6 Analysis of Market U-Shaped Recovery Pattern 13.3.7 Analysis of Market L-Shaped Recovery Pattern 13.4 China Pharmaceutical Contract Manufacturing Market Analysis 13.4.1 Chinese Demand for Pharma Contract Manufacturing Services 13.4.2 Improved Manufacturing Regulations in China 13.4.3 Regulations for Excipients and Guidance for API Manufacturing 13.4.4 What Are the Consequences to Stricter Manufacturing Regulations in China? 13.4.5 Chinese CMOs Are Investing in Biopharma Manufacturing 13.4.6 China Pharma Contract Manufacturing Market 13.4.7 Analysis of Market Status Before COVID-19 13.4.8 Analysis of Market V-Shaped Recovery Pattern 13.4.9 Analysis of Market W-Shaped Recovery Pattern 13.4.10 Analysis of Market U-Shaped Recovery Pattern 13.4.11 Analysis of Market L-Shaped Recovery Pattern 13.5 India Pharmaceutical Contract Manufacturing Market Analysis 13.5.1 Regulatory Outlook for Indian Pharma Manufacturing 13.5.2 Stricter Quality Standards to Ensure Compliance with EU Rules 13.5.3 Domestic Manufacturing Dominates the Indian Pharma Market 13.5.4 Demand for Contract Manufacturing in India 13.5.5 Analysis of Market Status Before COVID-19 13.5.6 Analysis of Market V-Shaped Recovery Pattern 13.5.7 Analysis of Market W-Shaped Recovery Pattern 13.5.8 Analysis of Market U-Shaped Recovery Pattern 13.5.9 Analysis of Market L-Shaped Recovery Pattern 13.6 South Korea Pharmaceutical Contract Manufacturing Market Analysis 13.6.1 South Korea: Government Supported Growth 13.6.2 South Korea: Strict GMP Regulations 13.6.3 South Korea: Pharma Contract Manufacturing Market 13.6.4 Analysis of Market Status Before COVID-19 13.6.5 Analysis of Market V-Shaped Recovery Pattern 13.6.6 Analysis of Market W-Shaped Recovery Pattern 13.6.7 Analysis of Market U-Shaped Recovery Pattern 13.6.8 Analysis of Market L-Shaped Recovery Pattern 13.7 Australia Pharmaceutical Contract Manufacturing Market Analysis 13.7.1 Analysis of Market Status Before COVID-19 13.7.2 Analysis of Market V-Shaped Recovery Pattern 13.7.3 Analysis of Market W-Shaped Recovery Pattern 13.7.4 Analysis of Market U-Shaped Recovery Pattern 13.7.5 Analysis of Market L-Shaped Recovery Pattern 13.8 Rest of APAC Pharmaceutical Contract Manufacturing Market Analysis 13.8.1 Analysis of Market Status Before COVID-19 13.8.2 Analysis of Market V-Shaped Recovery Pattern 13.8.3 Analysis of Market W-Shaped Recovery Pattern 13.8.4 Analysis of Market U-Shaped Recovery Pattern 13.8.5 Analysis of Market L-Shaped Recovery Pattern 13.9 Asia-Pacific Market Analysis by Product Category 13.9.1 Analysis of Market Status Before COVID-19 13.9.2 Analysis of Market V-Shaped Recovery Pattern 13.9.3 Analysis of Market W-Shaped Recovery Pattern 13.9.4 Analysis of Market U-Shaped Recovery Pattern 13.9.5 Analysis of Market L-Shaped Recovery Pattern 13.10 Asia-Pacific Market Analysis by Drug Type 13.10.1 Analysis of Market Status Before COVID-19 13.10.2 Analysis of Market V-Shaped Recovery Pattern 13.10.3 Analysis of Market W-Shaped Recovery Pattern 13.10.4 Analysis of Market U-Shaped Recovery Pattern 13.10.5 Analysis of Market L-Shaped Recovery Pattern 13.11 Asia-Pacific Market Analysis by API Contract Manufacturing 13.11.1 Analysis of Market Status Before COVID-19 13.11.2 Analysis of Market V-Shaped Recovery Pattern 13.11.3 Analysis of Market W-Shaped Recovery Pattern 13.11.4 Analysis of Market U-Shaped Recovery Pattern 13.11.5 Analysis of Market L-Shaped Recovery Pattern 13.12 Asia-Pacific Market Analysis by FDF Contract Manufacturing 13.12.1 Analysis of Market Status Before COVID-19 13.12.2 Analysis of Market V-Shaped Recovery Pattern 13.12.3 Analysis of Market W-Shaped Recovery Pattern 13.12.4 Analysis of Market U-Shaped Recovery Pattern 13.12.5 Analysis of Market L-Shaped Recovery Pattern 13.13 Asia-Pacific Market Analysis by End-User 13.13.1 Analysis of Market Status Before COVID-19 13.13.2 Analysis of Market V-Shaped Recovery Pattern 13.13.3 Analysis of Market W-Shaped Recovery Pattern 13.13.4 Analysis of Market U-Shaped Recovery Pattern 13.13.5 Analysis of Market L-Shaped Recovery Pattern 14 Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis 14.1 Middle East & Africa Market in Terms of Value 14.1.1 Analysis of Market Status Before COVID-19 14.1.2 Analysis of Market V-Shaped Recovery Pattern 14.1.3 Analysis of Market W-Shaped Recovery Pattern 14.1.4 Analysis of Market U-Shaped Recovery Pattern 14.1.5 Analysis of Market L-Shaped Recovery Pattern 14.2 Turkey Pharmaceutical Contract Manufacturing Market Analysis 14.2.1 Turkey: Domestic Market to offer Huge Growth Opportunities 14.2.2 Turkey: An Important Hub for Global Pharma Companies 14.2.3 Drug Approvals Delaying Growth of the Turkey Pharma Market 14.2.4 Analysis of Market Status Before COVID-19 14.2.5 Analysis of Market V-Shaped Recovery Pattern 14.2.6 Analysis of Market W-Shaped Recovery Pattern 14.2.7 Analysis of Market U-Shaped Recovery Pattern 14.2.8 Analysis of Market L-Shaped Recovery Pattern 14.3 Saudi Arabia Pharmaceutical Contract Manufacturing Market Analysis 14.3.1 Analysis of Market Status Before COVID-19 14.3.2 Analysis of Market V-Shaped Recovery Pattern 14.3.3 Analysis of Market W-Shaped Recovery Pattern 14.3.4 Analysis of Market U-Shaped Recovery Pattern 14.3.5 Analysis of Market L-Shaped Recovery Pattern 14.4 South Africa Pharmaceutical Contract Manufacturing Market Analysis 14.4.1 Analysis of Market Status Before COVID-19 14.4.2 Analysis of Market V-Shaped Recovery Pattern 14.4.3 Analysis of Market W-Shaped Recovery Pattern 14.4.4 Analysis of Market U-Shaped Recovery Pattern 14.4.5 Analysis of Market L-Shaped Recovery Pattern 14.5 UAE Pharmaceutical Contract Manufacturing Market Analysis 14.5.1 Analysis of Market Status Before COVID-19 14.5.2 Analysis of Market V-Shaped Recovery Pattern 14.5.3 Analysis of Market W-Shaped Recovery Pattern 14.5.4 Analysis of Market U-Shaped Recovery Pattern 14.5.5 Analysis of Market L-Shaped Recovery Pattern 14.6 Egypt Pharmaceutical Contract Manufacturing Market Analysis 14.6.1 Analysis of Market Status Before COVID-19 14.6.2 Analysis of Market V-Shaped Recovery Pattern 14.6.3 Analysis of Market W-Shaped Recovery Pattern 14.6.4 Analysis of Market U-Shaped Recovery Pattern 14.6.5 Analysis of Market L-Shaped Recovery Pattern 14.7 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis 14.7.1 Analysis of Market Status Before COVID-19 14.7.2 Analysis of Market V-Shaped Recovery Pattern 14.7.3 Analysis of Market W-Shaped Recovery Pattern 14.7.4 Analysis of Market U-Shaped Recovery Pattern 14.7.5 Analysis of Market L-Shaped Recovery Pattern 14.8 Middle East & Africa Market Analysis by Product Category 14.8.1 Analysis of Market Status Before COVID-19 14.8.2 Analysis of Market V-Shaped Recovery Pattern 14.8.3 Analysis of Market W-Shaped Recovery Pattern 14.8.4 Analysis of Market U-Shaped Recovery Pattern 14.8.5 Analysis of Market L-Shaped Recovery Pattern 14.9 Middle East & Africa Market Analysis by Drug Type 14.9.1 Analysis of Market Status Before COVID-19 14.9.2 Analysis of Market V-Shaped Recovery Pattern 14.9.3 Analysis of Market W-Shaped Recovery Pattern 14.9.4 Analysis of Market U-Shaped Recovery Pattern 14.9.5 Analysis of Market L-Shaped Recovery Pattern 14.10 Middle East & Africa Market Analysis by API Contract Manufacturing 14.10.1 Analysis of Market Status Before COVID-19 14.10.2 Analysis of Market V-Shaped Recovery Pattern 14.10.3 Analysis of Market W-Shaped Recovery Pattern 14.10.4 Analysis of Market U-Shaped Recovery Pattern 14.10.5 Analysis of Market L-Shaped Recovery Pattern 14.11 Middle East & Africa Market Analysis by FDF Contract Manufacturing 14.11.1 Analysis of Market Status Before COVID-19 14.11.2 Analysis of Market V-Shaped Recovery Pattern 14.11.3 Analysis of Market W-Shaped Recovery Pattern 14.11.4 Analysis of Market U-Shaped Recovery Pattern 14.11.5 Analysis of Market L-Shaped Recovery Pattern 14.12 Middle East & Africa Market Analysis by End-User 14.12.1 Analysis of Market Status Before COVID-19 14.12.2 Analysis of Market V-Shaped Recovery Pattern 14.12.3 Analysis of Market W-Shaped Recovery Pattern 14.12.4 Analysis of Market U-Shaped Recovery Pattern 14.12.5 Analysis of Market L-Shaped Recovery Pattern 15 Latin America Pharmaceutical Contract Manufacturing Market Analysis 15.1 Latin America Market in Terms of Value 15.1.1 Analysis of Market Status Before COVID-19 15.1.2 Analysis of Market V-Shaped Recovery Pattern 15.1.3 Analysis of Market W-Shaped Recovery Pattern 15.1.4 Analysis of Market U-Shaped Recovery Pattern 15.1.5 Analysis of Market L-Shaped Recovery Pattern 15.2 Brazil Pharmaceutical Contract Manufacturing Market Analysis 15.2.1 Pharmaceutical Manufacturing Regulations in Brazil 15.2.2 Brazil Imports Most of its APIs 15.2.3 Brazil: Pharma Contract Manufacturing Market 15.2.4 Analysis of Market Status Before COVID-19 15.2.5 Analysis of Market V-Shaped Recovery Pattern 15.2.6 Analysis of Market W-Shaped Recovery Pattern 15.2.7 Analysis of Market U-Shaped Recovery Pattern 15.2.8 Analysis of Market L-Shaped Recovery Pattern 15.3 Mexico Pharmaceutical Contract Manufacturing Market Analysis 15.3.1 Mexico: Emerging Market Power 15.3.2 Healthcare - A Top Priority in Mexico 15.3.3 Strategic Management of High Expectations 15.3.4 Mexico: Pharma Contract Manufacturing Market 15.3.5 Analysis of Market Status Before COVID-19 15.3.6 Analysis of Market V-Shaped Recovery Pattern 15.3.7 Analysis of Market W-Shaped Recovery Pattern 15.3.8 Analysis of Market U-Shaped Recovery Pattern 15.3.9 Analysis of Market L-Shaped Recovery Pattern 15.4 Argentina Pharmaceutical Contract Manufacturing Market Analysis 15.4.1 Analysis of Market Status Before COVID-19 15.4.2 Analysis of Market V-Shaped Recovery Pattern 15.4.3 Analysis of Market W-Shaped Recovery Pattern 15.4.4 Analysis of Market U-Shaped Recovery Pattern 15.4.5 Analysis of Market L-Shaped Recovery Pattern 15.5 Rest of Latin America Pharmaceutical Contract Manufacturing Market Analysis 15.5.1 Analysis of Market Status Before COVID-19 15.5.2 Analysis of Market V-Shaped Recovery Pattern 15.5.3 Analysis of Market W-Shaped Recovery Pattern 15.5.4 Analysis of Market U-Shaped Recovery Pattern 15.5.5 Analysis of Market L-Shaped Recovery Pattern 15.6 Latin America Market Analysis by Product Category 15.6.1 Analysis of Market Status Before COVID-19 15.6.2 Analysis of Market V-Shaped Recovery Pattern 15.6.3 Analysis of Market W-Shaped Recovery Pattern 15.6.4 Analysis of Market U-Shaped Recovery Pattern 15.6.5 Analysis of Market L-Shaped Recovery Pattern 15.7 Latin America Market Analysis by Drug Type 15.7.1 Analysis of Market Status Before COVID-19 15.7.2 Analysis of Market V-Shaped Recovery Pattern 15.7.3 Analysis of Market W-Shaped Recovery Pattern 15.7.4 Analysis of Market U-Shaped Recovery Pattern 15.7.5 Analysis of Market L-Shaped Recovery Pattern 15.8 Latin America Market Analysis by API Contract Manufacturing 15.8.1 Analysis of Market Status Before COVID-19 15.8.2 Analysis of Market V-Shaped Recovery Pattern 15.8.3 Analysis of Market W-Shaped Recovery Pattern 15.8.4 Analysis of Market U-Shaped Recovery Pattern 15.8.5 Analysis of Market L-Shaped Recovery Pattern 15.9 Latin America Market Analysis by FDF Contract Manufacturing 15.9.1 Analysis of Market Status Before COVID-19 15.9.2 Analysis of Market V-Shaped Recovery Pattern 15.9.3 Analysis of Market W-Shaped Recovery Pattern 15.9.4 Analysis of Market U-Shaped Recovery Pattern 15.9.5 Analysis of Market L-Shaped Recovery Pattern 15.10 Latin America Market Analysis by End-User 15.10.1 Analysis of Market Status Before COVID-19 15.10.2 Analysis of Market V-Shaped Recovery Pattern 15.10.3 Analysis of Market W-Shaped Recovery Pattern 15.10.4 Analysis of Market U-Shaped Recovery Pattern 15.10.5 Analysis of Market L-Shaped Recovery Pattern 16 Competitive Landscape 16.1 Strategy and Tactics: The Importance of Outsourcing Wisely 16.2 Market Leaders 16.3 Market Shares 16.3.1 Bulk Drugs and APIs 16.3.2 Solid Dosage Forms 16.3.3 Liquid Dosage Forms 16.3.4 Semi-Solid Dosage Forms 16.4 Contract Research 16.4.1 Market Leaders 16.4.2 Market Shares 17 Key Player Profiles 17.1 Catalent Inc. 17.1.1 Company Details 17.1.2 Company Overview 17.1.3 Company Financial Analysis 17.1.4 Catalent Inc.: Company Revenue Analysis 17.2 Lonza Group AG 17.2.1 Company Details 17.2.2 Company Overview 17.2.3 Company Financial Analysis 17.2.4 Lonza Group AG: Company Revenue Analysis 17.3 Evonik Industries AG 17.3.1 Company Details 17.3.2 Company Overview 17.3.3 Company Financial Analysis 17.3.4 Evonik Industries AG: Company Revenue Analysis 17.4 Teva Pharmaceutical Industries Ltd 17.4.1 Company Details 17.4.2 Company Overview 17.4.3 Company Financial Analysis 17.4.4 Teva Pharmaceutical Industries Ltd: Company Revenue Analysis 17.5 Mylan NV 17.5.1 Company Details 17.5.2 Company Overview 17.5.3 Company Financial Analysis 17.5.4 Mylan NV: Company Revenue Analysis 17.6 AbbVie Inc 17.6.1 Company Details 17.6.2 Company Overview 17.6.3 Company Financial Analysis 17.6.4 AbbVie Inc: Company Revenue Analysis 17.7 Piramal Enterprises Ltd 17.7.1 Company Details 17.7.2 Company Overview 17.7.3 Company Financial Analysis 17.7.4 Piramal Enterprises Ltd: Company Revenue Analysis 17.8 Consort Medical plc 17.8.1 Company Details 17.8.2 Company Overview 17.8.3 Company Financial Analysis 17.8.4 Consort Medical plc: Company Revenue Analysis 17.9 Baxter International Inc 17.9.1 Company Details 17.9.2 Company Overview 17.9.3 Company Financial Analysis 17.9.4 Baxter International Inc: Company Revenue Analysis 17.10 Alkermes Plc 17.10.1 Company Details 17.10.2 Company Overview 17.10.3 Company Financial Analysis 17.10.4 Alkermes Plc: Company Revenue Analysis 17.11 Bayer AG 17.11.1 Company Details 17.11.2 Company Overview 17.11.3 Company Financial Analysis 17.11.4 Bayer AG: Company Revenue Analysis 17.12 GlaxoSmithKline plc 17.12.1 Company Details 17.12.2 Company Overview 17.12.3 Company Financial Analysis 17.12.4 GlaxoSmithKline plc: Company Revenue Analysis 17.13 NIPRO Corporation 17.13.1 Company Details 17.13.2 Company Overview 17.13.3 Company Financial Analysis 17.13.4 NIPRO Corporation: Company Revenue Analysis 18 Conclusion and Recommendations 18.1 Will Product Reformulation Drive Growth to 2030? 18.2 Demand for Biopharma Manufacturing Will Drive Growth 2020-2030 18.3 Demand Will Be Highest Among Developed-Market Clients 18.4 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2030? 19 Glossary List of Figures Figure 3.1 Prominent Factors Affecting Growth of Pharmaceutical Contract Manufacturing Market Figure 3.2 Market Drivers For Growth of Pharmaceutical Contract Manufacturing Market Figure 3.3 Opportunities in the Global Pharmaceutical Contract Manufacturing Market Figure 3.4 Growth Restrains in the Global Pharmaceutical Contract Manufacturing Market Figure 3.5 SWOT Analysis of Pharmaceutical Contract Manufacturing Market Figure 3.6 Porter's Five Forces Analysis of Pharmaceutical Contract Manufacturing Market Figure 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) Figure 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 5.11 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) Figure 5.12 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 5.13 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 5.14 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 5.15 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 5.16 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) Figure 5.17 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 5.18 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 5.19 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 5.20 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 5.21 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) Figure 5.22 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 5.23 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 5.24 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 5.25 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 5.26 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) Figure 5.27 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 5.28 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 5.29 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 5.30 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 5.31 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) Figure 5.32 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 5.33 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 5.34 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 5.35 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 6.1 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 6.2 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 6.3 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 6.4 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 6.5 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 6.6 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 6.7 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 6.8 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 6.9 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 6.10 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 7.1 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 7.2 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 7.3 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 7.4 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 7.5 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 7.6 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 7.7 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 7.8 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 7.9 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 7.10 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 8.1 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 8.2 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 8.3 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 8.4 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 8.5 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 8.6 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 8.7 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 8.8 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 8.9 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 8.10 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 8.11 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 8.12 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 8.13 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 8.14 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 8.15 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 9.1 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 9.2 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 9.3 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 9.4 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 9.5 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 9.6 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 9.7 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 9.8 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 9.9 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 9.10 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 9.11 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 9.12 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 9.13 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 9.14 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 9.15 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 9.16 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 9.17 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 9.18 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 9.19 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 9.20 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 10.1 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 10.2 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 10.3 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 10.4 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 10.5 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 10.6 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 10.7 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 10.8 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 10.9 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 10.10 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 10.11 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 10.12 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 10.13 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 10.14 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 10.15 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 10.16 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) Figure 10.17 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 10.18 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 10.19 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 10.20 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 11.1 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) Figure 11.2 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 11.3 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 11.4 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 11.5 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 11.6 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) Figure 11.7 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 11.8 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 11.9 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 11.10 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 11.11 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) Figure 11.12 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 11.13 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 11.14 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 11.15 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 11.16 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) Figure 11.17 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 11.18 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 11.19 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 11.20 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 11.21 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) Figure 11.22 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 11.23 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 11.24 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 11.25 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 11.26 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) Figure 11.27 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 11.28 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 11.29 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 11.30 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 12.1 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) Figure 12.2 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 12.3 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 12.4 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 12.5 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 12.6 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) Figure 12.7 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 12.8 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 12.9 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 12.10 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 12.11 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) Figure 12.12 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 12.13 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 12.14 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 12.15 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 12.16 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) Figure 12.17 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 12.18 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 12.19 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 12.20 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 12.21 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) Figure 12.22 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 12.23 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 12.24 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 12.25 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 12.26 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) Figure 12.27 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 12.28 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 12.29 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 12.30 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 13.1 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) Figure 13.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 13.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 13.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 13.5 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 13.6 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) Figure 13.7 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 13.8 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 13.9 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 13.10 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 13.11 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) Figure 13.12 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 13.13 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 13.14 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 13.15 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 13.16 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) Figure 13.17 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 13.18 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 13.19 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 13.20 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 13.21 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) Figure 13.22 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 13.23 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 13.24 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 13.25 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 13.26 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) Figure 13.27 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 13.28 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 13.29 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 13.30 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 14.1 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) Figure 14.2 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 14.3 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 14.4 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 14.5 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 14.6 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) Figure 14.7 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 14.8 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 14.9 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 14.10 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 14.11 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) Figure 14.12 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 14.13 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 14.14 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 14.15 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 14.16 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) Figure 14.17 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 14.18 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 14.19 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 14.20 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 14.21 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) Figure 14.22 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 14.23 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 14.24 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 14.25 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 14.26 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) Figure 14.27 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 14.28 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 13.29 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 14.30 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 15.1 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) Figure 15.2 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 15.3 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 15.4 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 15.5 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 15.6 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) Figure 15.7 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 15.8 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 15.9 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 15.10 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 15.11 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) Figure 15.12 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 15.13 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 15.14 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 15.15 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) Figure 15.16 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 15.17 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 15.18 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 15.19 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 15.20 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) Figure 15.21 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 15.22 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 15.23 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 15.24 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 15.25 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) Figure 15.26 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery) Figure 15.27 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery) Figure 15.28 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery) Figure 15.29 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery) Figure 17.1 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.2 Catalent Inc. Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.3 Catalent Inc. Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.4 Catalent Inc. Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.5 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.6 Lonza Group AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.7 Lonza Group AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.8 Lonza Group AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.9 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.10 Evonik Industries AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.11 Evonik Industries AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.12 Evonik Industries AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.13 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.14 Teva Pharmaceutical Industries Ltd Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.15 Teva Pharmaceutical Industries Ltd Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.16 Teva Pharmaceutical Industries Ltd Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.17 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.18 Mylan NV Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.19 Mylan NV Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.20 Mylan NV Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.21 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.22 AbbVie Inc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.23 AbbVie Inc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.24 AbbVie Inc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.25 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.26 Piramal Enterprises Ltd Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.27 Piramal Enterprises Ltd Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.28 Piramal Enterprises Ltd Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.29 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.30 Consort Medical plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.31 Consort Medical plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.32 Consort Medical plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.33 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.34 Baxter International Inc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.35 Baxter International Inc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.36 Baxter International Inc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.37 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.38 Alkermes Plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.39 Alkermes Plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.40 Alkermes Plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.41 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.42 Bayer AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.43 Bayer AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.44 Bayer AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.45 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.46 GlaxoSmithKline plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.47 GlaxoSmithKline plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.48 GlaxoSmithKline plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) Figure 17.49 Company Revenue 2015-2019 (US$Mn, AGR %) Figure 17.50 NIPRO Corporation Company Operating Income Analysis 2015-2019 (US$Mn, AGR %) Figure 17.51 NIPRO Corporation Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %) Figure 17.52 NIPRO Corporation Company EBITDA Analysis 2015-2019 (US$Mn, AGR %) List of Tables Table 2.1 Global Pharmaceutical Contract Manufacturing Market Summary Table Table 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 5.11 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 5.12 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 5.13 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 5.14 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 5.15 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 5.16 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 5.17 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 5.18 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 5.19 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 5.20 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 5.21 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 5.22 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 5.23 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 5.24 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 5.25 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 5.26 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 5.27 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 5.28 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 5.29 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 5.30 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 5.31 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 5.32 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 5.33 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 5.34 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 5.35 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 6.1 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 6.2 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 6.3 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 6.4 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 6.5 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 6.6 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 6.7 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 6.8 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 6.9 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 6.10 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 7.1 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 7.2 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 7.3 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 7.4 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 7.5 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 7.6 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 7.7 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 7.8 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 7.9 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 7.10 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 8.1 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 8.2 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 8.3 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 8.4 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 8.5 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 8.6 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 8.7 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 8.8 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 8.9 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 8.10 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 8.11 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 8.12 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 8.13 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 8.14 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 8.15 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 9.1 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 8.2 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 9.3 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 8.4 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 9.5 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 9.6 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 9.7 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 9.8 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 9.9 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 9.10 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 9.11 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 9.12 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 9.13 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 9.14 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 9.15 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 9.16 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 9.17 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 9.18 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 9.19 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 9.20 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 10.1 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 10.2 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 10.3 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 10.4 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 10.5 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 10.6 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 10.7 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 10.8 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 10.9 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 10.10 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 10.11 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 10.12 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 10.13 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 10.14 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 10.15 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 10.16 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 10.17 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 10.18 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 10.19 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 10.20 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 11.1 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 11.2 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 11.3 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.4 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 11.5 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 11.6 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 11.7 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 11.8 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.9 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 11.10 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 11.11 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 11.12 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 11.13 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.14 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 11.15 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 11.16 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 11.17 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 11.18 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.19 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 11.20 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 11.21 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 11.22 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 11.23 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.24 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 11.25 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 11.26 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 11.27 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 11.28 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.29 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 11.30 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 11.31 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 11.32 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 11.33 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.34 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 11.35 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 11.36 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 11.37 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 11.38 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.39 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 11.40 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.1 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.2 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.3 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.4 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.5 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.6 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.7 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.8 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.9 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.10 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.11 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.12 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.13 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.14 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.15 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.16 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.17 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.18 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.19 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.20 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.21 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.22 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.23 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.24 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.25 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.26 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.27 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.28 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.29 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.30 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.31 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.32 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.33 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.34 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.35 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.36 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.37 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.38 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.39 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.40 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.41 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.42 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.43 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 11.44 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.45 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.46 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.47 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.48 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.49 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.50 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.51 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.52 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.53 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.54 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.55 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 12.56 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 12.57 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 12.58 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 12.59 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 12.60 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.1 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.5 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.6 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.7 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.8 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.9 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.10 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.11 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.12 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.13 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.14 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.15 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.16 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.17 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.18 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.19 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.20 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.21 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.22 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.23 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.24 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.25 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.26 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.27 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.28 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.29 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.30 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.31 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.32 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.33 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.34 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.35 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.36 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.37 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.38 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.39 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.40 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.41 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.42 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.43 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.44 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.45 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.46 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.47 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.48 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.49 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.50 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.51 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.52 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.53 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.54 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.55 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 13.56 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 13.57 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 13.58 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 13.59 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 13.60 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.1 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.2 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.3 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.4 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.5 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.6 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.7 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.8 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.9 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.10 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.11 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.12 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.13 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.14 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.15 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.16 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.17 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.18 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.19 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.20 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.21 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.22 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.23 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.24 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.25 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.26 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.27 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.28 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.29 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.30 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.31 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.32 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.33 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.34 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.35 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.36 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.37 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.38 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.39 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.40 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.41 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.42 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.43 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.44 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.45 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.46 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.47 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.48 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.49 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.50 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.51 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.52 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.53 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.54 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.55 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.56 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 14.57 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 14.58 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 14.59 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 14.60 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 15.1 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.2 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.3 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.4 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.5 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 15.6 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.7 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.8 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.9 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.10 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 14.11 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.12 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.13 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.14 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.15 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 15.16 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.17 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.18 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.19 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.20 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 15.21 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.22 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.23 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.24 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.25 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 15.26 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.27 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.28 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.29 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.30 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 15.31 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.32 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.33 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.34 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.35 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.36 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.37 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.38 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.39 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 15.40 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.41 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.42 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.43 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.44 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 15.45 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) Table 15.46 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery) Table 15.47 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery) Table 15.48 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery) Table 15.49 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery) Table 16.1 Services Provided by Leading Pharmaceutical Contract Manufacturing Companies, 2019 Table 16.2 Global Market Share of Contract Manufacturing Companies Providing Bulk Drugs and APIs, 2019 (%) Table 16.3 Global Market Share of Contract Manufacturing Companies Providing Solid Dosage Forms, 2019, (%) Table 16.4 Global Market Share of Contract Manufacturing Companies Providing Nonsterile Liquid Dosage Forms, 2019 (%) Table 16.5 Global Market Share of Contract Manufacturing Companies Providing Sterile Liquid Dosage Forms, 2019 Table 16.6 Global Market Share of Contract Manufacturing Companies Providing Semi-Solid Dosage Forms, 2019 (%) Table 16.7 Services Provided by Leading Research Firms, 2019 Table 16.8 Global Market Share of Contract Research Companies, 2019 Table 16.9 Contracting Companies Offering Drug-Delivery Technologies and Systems, 2019 Table 17.1 Catalent Inc. (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.2 Catalent Inc. Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.3 Lonza Group AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.4 Lonza Group AG Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.5 Evonik Industries AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.6 Evonik Industries AG Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.7 Teva Pharmaceutical Industries Ltd (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.8 Teva Pharmaceutical Industries Ltd Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.9 Mylan NV (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.10 Mylan NV Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.11 AbbVie Inc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.12 AbbVie Inc Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.13 Piramal Enterprises Ltd (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.14 Piramal Enterprises Ltd Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.15 Consort Medical plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.16 Consort Medical plc Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.17 Baxter International Inc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.18 Baxter International Inc Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.19 Alkermes Plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.20 Alkermes Plc Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.21 Bayer AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.22 Bayer AG Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.23 GlaxoSmithKline plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.24 GlaxoSmithKline plc Company Revenue 2015-2019 (US$Mn, AGR %) Table 17.25 NIPRO Corporation (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website) Table 17.26 NIPRO Corporation Company Revenue 2015-2019 (US$Mn, AGR %)

Companies Profiled in the Report AbbVie Inc Alkermes Plc Baxter International Inc Bayer AG Catalent Inc. Consort Medical plc Evonik Industries AG GlaxoSmithKline plc Lonza Group AG Mylan NV NIPRO CORPORATION Piramal Enterprises Ltd Teva Pharmaceutical Industries Ltd List of Companies Mentioned in the Report AbbVie Actavis ADC Biotechnology Aegerion Pharmaceuticals Aenova Group Aesica Pharma Agensys Agila Specialties Ajinomoto Althea Inc Alexion Pharmaceuticals Almac Group Althea Technologies AMRI (Albany Molecular Research Inc) API Corporation (APIC) Aspen Pharmacare Astellas AstraZeneca Banner Life Sciences Banner Pharmacaps Baring Private Equity Asia Bausch & Lomb Bayer Healthcare Ben Venue Laboratories Bend Research Biogen Idec BioIndustry Association (BIA) Biotest Blackstone Group Boehringer Ingelheim Boehringer Ingelheim BioXcellence Bristol-Myers Squibb Company Bushu Pharmaceuticals Cambrex Cambridge Major Laboratories Catalent Pharma Solutions Cedarburg Hauser Cell Therapy Catapult Celldex Therapeutics Celltrion Cenexi Chemisch-Pharmazeutisches Laboratorium Ravensburg Chemtrix China FDA (CFDA) Cipla Cook Pharmica CordenPharma CTC Bio Daito Pharmaceutical Delpharm Dishman Pharmaceuticals DPx Fine Chemicals DPx Holdings B.V. Dr. Reddy's Laboratories DSP (DSM Sinochem Pharmaceuticals) Eisai Eli Lilly Esteve Quimica Euticals Evonik Degussa Famar Fareva FUJIFILM Diosynth Biotechnologies, G-CON Gallus Biopharmaceutical, LLC. GEA Pharma-Systems Genentech GlaxoSmithKline (GSK) Granules India Haupt Pharma Hexal Hospira Hospira One2One ImmunoGen Immunomedics Indian Pharmaceutical Alliance Innovent Biologics IRIX Pharmaceuticals Janssen JK Pharmaceutical Johnson & Johnson Knowledge Transfer Network (KTN) Lonza Lupin Marinopoulos Group Matrix Laboratories Medice Medichem Merck & Co. Micron Technologies Millennium Mitsui & Co Momenta Pharmaceuticals Mylan Neuland Laboratories NICE Insight NPS Pharmaceuticals Nycomed Orchid Chemicals & Pharmaceuticals Oxford Biomedica Patheon Patheon Biologics Pfizer Pharmapak Technologies Piramal Pharma Solutions Progenics Quintiles Recepta Biopharma Recipharm Redwood Bioscience Rentschler Biotechnologie Roche Royal DSM SAFC SafeBridge Samsung Bioepis Samsung BioLogics Sandoz Sanofi Seattle Genetics Shandong Xinhua ShangPharma Shire Siegfried AG Sigmar Italia SMS Pharmaceuticals Solvias AG Speedel Stada Stem CentRx Stevenage Bioscience Catalyst Takeda Temmler Group Teva API Thermo Fisher Scientific UMN Pharma UNIGEN Valeant Pharmaceuticals Valerion Therapeutics, LLC. Vetter Pharma-Fertigung GmbH Vivante GMP Solutions West Pharmaceutical Services WuXi PharmaTech Zhangjiang Biotech & Pharmaceutical Base Company Zhejiang Jiang Yuan Tang Biotechnology List of Organizations Mentioned in the Report AgÃªncia Nacional de VigilÃ¢ncia Sanitária (ANVISA) Asociación EspaÃ±ola de Fabricantes de Productos de QuÃmica Fina (AFAQUIM) Associação Brasileira da Indústria FarmoquÃmica e de Insumos FarmacÃªuticos (ABIQUIFI) Association of British Pharmaceutical Industry (ABPI) Central Drugs Standard Control Organization (CDSCO) Department of Health and Family Welfare Development and Reform Commission (NDRC) European Commission European Medicines Agency (EMA) Food and Drug Administration (US FDA) Indian Drug Manufacturer's Association (IDMA) International Society of Pharmaceutical Engineering (IPSE) Korea Food and Drug Administration (KFDA) Korea Pharmaceutical Manufacturer's Association (KPMA) Medicines and Healthcare Products Regulatory Agency (MHRA) Medicines Manufacturing Industry Partnership (MMIP) Ministry of Health (MOH) Ministry of Health, Labor and Welfare (MHLW) Ministry of Industry and Information Technology (MIIT) Pharmaceutical and Medical Devices Agency (PMDA) World Health Organization (WHO)